Researchers at Oncode Institute and Princess Máxima Center have developed a new human model of the brainstem that is changing how one of the most aggressive childhood brain cancers can be studied. Read more: https://www.zonmw.nl/en/news/new-human-brain-model-deadly-childhood-brain-cancer

In a new study, Children’s Cancer Institute and UNSW Sydney researchers lab-tested a combined therapy approach on a group of difficult-to-treat brain tumours: diffuse midline gliomas (DMG). This group includes diffuse intrinsic pontine glioma (DIPG), a rare but fatal childhood brain cancer. Read more: https://www.unsw.edu.au/newsroom/news/2026/01/dual-therapy-shows-promise-for-childhood-brain-cancer

Ultrasound-created microbubbles can deliver anti-cancer drugs to tumors in difficult-to-reach areas such as the brain stem and spinal cord, a pilot study in children has revealed. Read more: https://www.insideprecisionmedicine.com/topics/oncology/ultrasound-driven-microbubbles-cross-blood-brain-barrier-to-treat-childhood-cancer/

Using fruit flies, University of Wisconsin–Madison researchers have developed a new model for investigating the genetic drivers of a rare but aggressive brain tumor in children. The work has already identified potential treatment targets for the deadly cancer that has previously had few therapeutic options. Read more: https://medicalxpress.com/news/2025-10-uncover-treatment-devastating-childhood-brain.html

Scientists at The Hormel Institute, University of Minnesota, have made a groundbreaking discovery that could lead to new treatments for...

CAR-T cells show promise against pediatric diffuse midline gliomas, brain and spinal cord tumors that are among the deadliest cancers, a...

CAR-T therapy, which harnesses a person’s own immune cells, racks up some astonishing success stories against deadly brain tumours in...

Researchers at Texas Children’s Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children’s...

An international team of investigators has identified a drug candidate that nearly doubles survival rates for patients with diffuse ...

For the first time, researchers have found a potential drug candidate that improved outcomes for patients with a type of childhood brain...